ADAGE CAPITAL PARTNERS GP LLC 13D/13G Filings for Aeglea BioTherapeutics, Inc. (AGLE)

ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Aeglea BioTherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-10
09:01 am
Sale		 2021-12-31 13G Aeglea BioTherapeutics, Inc.
AGLE		 ADAGE CAPITAL PARTNERS GP LLC 40,000
2.030%		 -79,680decrease
(-66.58%)		 Filing
2021-02-11
07:31 am
Purchase		 2020-12-31 13G Aeglea BioTherapeutics, Inc.
AGLE		 ADAGE CAPITAL PARTNERS GP LLC 119,680
6.240%		 60,936increase
(+103.73%)		 Filing